Senior insider sale
Chief Operating Officer at CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$6.65M
167.40K shares
What this filing means
KNIGHT JEFF E. plans to sell 167.40K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $6.65M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/2/2026ACC: 0001950047-26-006832
Officer· Chief Operating Officer
Since Aug 2021
167.40K
Shares to sell
$6.65M
Approx. market value
47.42K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
7/2/2026
44.92KRestricted Stock Units
N/A
3/15/2025
2.50KTotal acquired47.42K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/2/2026 | Exercise of Stock Options Cash | 44.92K | — |
3/15/2025 | Restricted Stock Units N/A | 2.50K | — |
| Total | 47.42K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
9.48K
Market value
$380.5K
5/4/2026
—Completed
Units to sell
20.90K
Market value
$839.1K
4/14/2026
—Completed
Units to sell
4.43K
Market value
$177.4K
4/13/2026
—Completed
Units to sell
85.16K
Market value
$3.41M
4/8/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
47.42K
Market value
$1.83M
7/2/2026
Total
Units
167.40K
Value
$6.65M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/4/2026 | 9.48K | $380.5K | — | Completed |
4/14/2026 | 20.90K | $839.1K | — | Completed |
4/13/2026 | 4.43K | $177.4K | — | Completed |
4/8/2026 | 85.16K | $3.41M | — | Completed |
| Planned — Approximate Date | ||||
7/2/2026 | 47.42K | $1.83M | NASDAQ | Planned |
| Total | 167.40K | $6.65M | ||